Celltrion Inc - Company Profile
Powered by 
All the sales intelligence you need on Celltrion Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Celltrion Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Celltrion Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Celltrion Clinical Trials
Determine Celltrion Inc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.
A sample of Celltrion Clinical Trials data
| Trial Title | Trial Identifier | Drug Name | Therapy Area | Indication | Trial Phase | Trial Status | Sponsor |
|---|---|---|---|---|---|---|---|
| Deserunt mollit sunt Lorem | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Pfizer Inc |
| A Phase I, Randomized, Open-label, Two-arm, Parallel Group, Single-dose Study to Compare the Pharmacokinetics and Safety of the Auto-injector and Pre-filled Syringe of CT-P47 in Healthy Subjects | GDCT0469831 | tocilizumab biosimilar | Immunology | Rheumatoid Arthritis | Phase I | Ongoing, recruiting | Celltrion Inc |
| A Bioequivalence Study of L04TD2 Compared to Administration of L04RD1 in Healthy Volunteers | GDCT0469706 | CTL-04 | Cardiovascular | Idiopathic (Essential) Hypertension | Phase I | Ongoing, not recruiting | Celltrion Inc |
| Investigating the Need to Continue Taking Immunomodulator Tablets for Patients with Inflammatory Bowel Disease, When Switching From Treatment with Intravenous Infliximab Infusions (Infliximab Given Directly Into a Vein) To Subcutaneous Infliximab (Infliximab Given by an Injection Under the Skin) | GDCT0469623 | azathioprine; infliximab biosimilar | Gastrointestinal | Crohn's Disease (Regional Enteritis); Inflammatory Bowel Disease; Ulcerative Colitis | Phase IV | Ongoing, recruiting | King''s Health Partners |
Feature
GlobalData’s Clinical Trials database (CTDB) is a highly comprehensive source of Clinical Trials.
The database covers planned, ongoing, completed and terminated/suspended/withdrawn clinical trials.
Clinical Trials database provides intelligence on global clinical trials for all indications. The data is sourced from:
- 250+ clinical trial registries
- 200+ scientific and investor conferences, company pipelines, press releases, and SEC filings.
Benefit
The Clinical Trials database collects information on various parameters to provide a Clinical Trial overview as well as Clinical Trial details, Drug details, Patient details, Trial Results, Location(s)/Sponsor(s) and Contact Detail(s).
Access:
- Detailed trial information.
- Drug information.
- Patient information, including inclusion and exclusion criteria.
- Trial results, as reported in the public domain.
- Biomarkers used for patient stratification/selection & outcome measures.
- Enrolment parameters.
- Investigators involved in clinical trials.
- Trials sites and locations.
- Contact information.
Value
Competitive Activity – keep an eye on planned or ongoing trials, as well as the trials currently recruiting and who is sponsoring them.
Geographic Analysis - see where trials are being run.
Trend Analysis - view top sponsors, indications, phase, status and more with Trial Analytics.
Find information on trials contacts, as well as Site and Investigator information.
Get information on trial successes and failures.
Get intelligence on CROs engaged in clinical trials.
Use as a business development tool for CROs.
Premium databases is part of our industry range of products
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer